Evolving Market Trends In The Anti-Rabies Serum Industry: Biopharmaceutical Partnership Aims To Prevent Rabies And Raise Disease Awareness In The US

The Anti-Rabies Serum Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Anti-Rabies Serum Market Size During the Forecast Period?
There has been significant growth in the anti-rabies serum market size over the past few years. It's expected that the market will escalate from a valuation of $1.42 billion in 2024 to $1.5 billion in 2025, representing a compound annual growth rate (CAGR) of 5.7%. The historical growth trajectory can be credited to factors like an increase in animal populations, broader vaccination programs, advancements in diagnostic methods, growth in travel and migration, as well as escalating public health initiatives and the rising number of wildlife encounters.

In the forthcoming years, the anti-rabies serum market is predicted to experience substantial growth, with the market size swelling to $1.85 billion by 2029, expanding at a Compound Annual Growth Rate (CAGR) of 5.4%. Factors contributing to this growth in the projection period include increased occurrence of animal bites, higher investments towards research on rabies, greater understanding of zoonotic diseases, improvements in storing and handling of serum, and escalated support towards rabies control initiatives. The forecast period will also witness emerging trends including the creation of novel serum formulations, advancements in the health care infrastructure, technological innovation in serum production, the inception of alternative delivery mechanisms, and the creation of quick diagnostic kits.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20468

What Are the High-Growth Segments in the Anti-Rabies Serum Market?
The anti-rabies serum market covered in this report is segmented -

1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals

Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20468&type=smp

What Key Drivers Are Expected to Influence Future Anti-Rabies Serum Market Growth?
The increasing occurrence of dog bites is anticipated to drive the expansion of the anti-rabies serum market. Dog bites, which can range from slight to serious, are injuries incurred from a dog's bite or scratch. Such bites may lead to severe wounds, infections and, in some situations, spread of diseases like rabies. Immediate medical care and effective prevention are key in managing the risks related with dog bites. The surge in dog bites can be attributed to several factors including increased urbanization, causing more frequent dog-human interactions, a rising number of unattended or poorly trained dogs, and inadequate knowledge or education regarding dog behavior and bite prevention. This surge has resulted in a heightened demand for anti-rabies serum as its immediate use is vital in preventing rabies in individuals who have come in contact with possibly infected animals. For example, according to the American Veterinary Medical Association, a not-for-profit organization based in the US, the average cost for dog bite insurance claims in 2023 was $58,545. Dog bite-related liability claims resulted in insurers paying out $1.12B in 2023. In the same year, dog bite claims saw an increase of nearly 10%. Hence, the escalating occurrence of dog bites is fueling the growth of the anti-rabies serum market.

Which Companies Hold the Largest Share Across Different Anti-Rabies Serum Market Segments?
Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd ., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals

What Trends Are Driving Growth in The Anesthesia Circuits Market?
Leading businesses in the anti-rabies serum market are engaging in strategic alliances to boost product development and widen their market footprint. These strategic alliances allow businesses to harness each other's strengths and resources for mutual success and benefit. A case in point is the July 2023 partnership between Kedrion S.p.A, a US-based biopharmaceutical business, and Kamada, an Israeli-based biopharmaceutical firm. This alliance allowed them to distribute KEDRAB (Rabies Immune Globulin [Human]) in the US. The collaboration was key in jointly developing and licensing the product in the U.S., and in promoting awareness of the disease. Accordingly, their combined efforts have effectively safeguarded people who were exposed to rabid animal bites from severe and potentially fatal conditions.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anti-rabies-serum-global-market-report

What Are the Emerging Geographies for The Anti-Rabies Serum Market Growth?
North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anti-Rabies Serum Market?
2. What is the CAGR expected in the Anti-Rabies Serum Market?
3. What Are the Key Innovations Transforming the Anti-Rabies Serum Industry?
4. Which Region Is Leading the Anti-Rabies Serum Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the anti-rabies serum market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.